TY - JOUR AU - Steinbrook, R. PY - 2008 DA - 2008// TI - The AIDS Epidemic - A Progress Report from Mexico City JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMp0805761 DO - 10.1056/NEJMp0805761 ID - Steinbrook2008 ER - TY - JOUR AU - McCune, J. PY - 2001 DA - 2001// TI - The dynamics of CD4+T-cell depletion in HIV disease JO - Nature VL - 410 UR - https://doi.org/10.1038/35073648 DO - 10.1038/35073648 ID - McCune2001 ER - TY - JOUR AU - Yeni, P. G. AU - Hammer, S. M. AU - Hirsch, M. AU - Saag, M. AU - Schechter, M. AU - Carpenter, C. C. J. AU - Fischi, M. A. AU - Gatell, J. M. AU - Gazzard, B. G. AU - Jacobsen, D. AU - Katzenstein, D. A. AU - Montaner, J. S. G. AU - Richman, D. D. AU - Schooley, R. T. AU - Thompson, M. A. AU - Vella, S. AU - Volberding, P. A. PY - 2004 DA - 2004// TI - Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society - USA Panel JO - JAMA VL - 292 UR - https://doi.org/10.1001/jama.292.2.251 DO - 10.1001/jama.292.2.251 ID - Yeni2004 ER - TY - JOUR AU - Staszewski, S. AU - Morales-Ramirez, J. AU - Tashima, K. T. AU - Rachlis, A. AU - Skiest, D. AU - Stanford, J. AU - Stryker, R. AU - Johnson, P. AU - Labriola, D. F. AU - Farina, D. AU - Manion, D. J. AU - Ruiz, N. M. PY - 1999 DA - 1999// TI - Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199912163412501 DO - 10.1056/NEJM199912163412501 ID - Staszewski1999 ER - TY - JOUR AU - Moyle, G. PY - 2003 DA - 2003// TI - Protease inhibitor-sparing regimens: new evidence strengthens position JO - J Acq Immun Def Synd VL - 33 ID - Moyle2003 ER - TY - JOUR AU - Atlice, F. L. AU - Friedland, G. H. PY - 1998 DA - 1998// TI - The era of adherence to HIV therapy JO - Ann Intern Med VL - 129 UR - https://doi.org/10.7326/0003-4819-129-6-199809150-00015 DO - 10.7326/0003-4819-129-6-199809150-00015 ID - Atlice1998 ER - TY - JOUR AU - Wahl, L. M. AU - Nowak, M. A. PY - 2000 DA - 2000// TI - Adherence and drug resistance: predictions for therapy outcome JO - Proc R Soc B VL - 267 UR - https://doi.org/10.1098/rspb.2000.1079 DO - 10.1098/rspb.2000.1079 ID - Wahl2000 ER - TY - JOUR AU - Philips, A. N. AU - Youle, M. AU - Johnson, M. AU - Loveday, C. PY - 2001 DA - 2001// TI - Use of stochastic model to develop understanding of the impact of different patterns of antiretroviral drug use on resistance development JO - AIDS VL - 15 UR - https://doi.org/10.1097/00002030-200111230-00001 DO - 10.1097/00002030-200111230-00001 ID - Philips2001 ER - TY - JOUR AU - Tchetgen, E. AU - Kaplan, E. H. AU - Friedland, G. H. PY - 2001 DA - 2001// TI - Public health consequences of screening patients for adherence to highly active antiretroviral therapy JO - J AIDS VL - 26 ID - Tchetgen2001 ER - TY - JOUR AU - Huang, Y. AU - Rosenkranz, S. AU - Wu, H. PY - 2003 DA - 2003// TI - Modeling HIV dynamics and antiviral response with consideration of time-varying drug exposures, adherence and phenotypic sensitivity JO - Math Biosci VL - 184 UR - https://doi.org/10.1016/S0025-5564(03)00058-0 DO - 10.1016/S0025-5564(03)00058-0 ID - Huang2003 ER - TY - JOUR AU - Huang, Y. AU - Liu, D. AU - H, W. PY - 2004 DA - 2004// TI - Hierarchical Bayesian methods for estimation of parameters in longitudinal HIV dynamic system JO - Biometrics VL - 62 UR - https://doi.org/10.1111/j.1541-0420.2005.00447.x DO - 10.1111/j.1541-0420.2005.00447.x ID - Huang2004 ER - TY - JOUR AU - Ferguson, N. M. AU - Donnelly, C. A. AU - Hooper, J. AU - Ghani, A. C. AU - Fraser, C. AU - Bartley, L. PY - 2005 DA - 2005// TI - Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients JO - J R Soc Interface VL - 2 UR - https://doi.org/10.1098/rsif.2005.0037 DO - 10.1098/rsif.2005.0037 ID - Ferguson2005 ER - TY - JOUR AU - Smith, R. J. PY - 2006 DA - 2006// TI - Adherence to antiretroviral HIV drugs: how many doses can you miss before resistance emerges? JO - Proc R Soc B VL - 273 UR - https://doi.org/10.1098/rspb.2005.3352 DO - 10.1098/rspb.2005.3352 ID - Smith2006 ER - TY - JOUR AU - Krakovska, O. AU - Wahl, L. M. PY - 2007 DA - 2007// TI - Optimal drug treatment regimens for HIV depend on adherence JO - J Theor Biol VL - 246 UR - https://doi.org/10.1016/j.jtbi.2006.12.038 DO - 10.1016/j.jtbi.2006.12.038 ID - Krakovska2007 ER - TY - JOUR AU - Friedland, G. H. AU - Williams, A. PY - 1999 DA - 1999// TI - Attaining higher goals in HIV treatment: the central importance of adherence JO - AIDS VL - 13 ID - Friedland1999 ER - TY - JOUR AU - Reijers, M. H. AU - Weverling, G. J. AU - Jurriaans, S. AU - Wit, F. W. AU - Weigel, H. M. AU - Ten Kate, R. W. AU - Mulder, J. W. AU - Frissen, P. H. AU - van Leeuwen, R. AU - Reiss, P. AU - Schuitemaker, H. AU - de Wolf, F. AU - Lange, J. M. PY - 1998 DA - 1998// TI - Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication study JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)06193-5 DO - 10.1016/S0140-6736(98)06193-5 ID - Reijers1998 ER - TY - JOUR AU - Havlir, D. V. AU - Marschner, I. C. AU - Hirsch, M. S. AU - Collier, A. C. AU - Tebas, P. AU - Bassett, R. L. AU - Ioannidis, J. P. AU - Holohan, M. K. AU - Leavitt, R. AU - Coone, G. AU - Richman, D. D. PY - 1998 DA - 1998// TI - Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199810293391801 DO - 10.1056/NEJM199810293391801 ID - Havlir1998 ER - TY - JOUR AU - Pialoux, G. AU - Raffi, F. AU - Brun-Vezinet, F. AU - Meiffrédy, V. AU - Flandre, P. AU - Gastaut, J. AU - Dellamonica, P. AU - Yeni, P. AU - Delfraissy, J. AU - Aboulker, J. PY - 1998 DA - 1998// TI - A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilege (Agence Nationale de Recherches sur le SIDA 072) Study Team JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199810293391802 DO - 10.1056/NEJM199810293391802 ID - Pialoux1998 ER - TY - JOUR AU - Descamps, D. AU - Flandre, P. AU - Calvez, V. AU - Peytavin, G. AU - Meiffrédy, V. AU - Collin, G. AU - Delaugerre, C. AU - Robert-Delmas, S. AU - Bazin, B. AU - Aboulker, J. P. AU - Pialoux, G. AU - Raffi, F. AU - Brun-Vézinet, F. PY - 2000 DA - 2000// TI - Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy JO - JAMA VL - 283 UR - https://doi.org/10.1001/jama.283.2.205 DO - 10.1001/jama.283.2.205 ID - Descamps2000 ER - TY - JOUR AU - Curlin, M. AU - Iyer, S. AU - Mittler, J. PY - 2007 DA - 2007// TI - Optimal timing and duration of induction therapy for HIV-1 infection JO - PLoS Comput Biol VL - 3 UR - https://doi.org/10.1371/journal.pcbi.0030133 DO - 10.1371/journal.pcbi.0030133 ID - Curlin2007 ER - TY - JOUR AU - Havlir, D. AU - Hellmann, N. S. AU - Petropoulos, C. J. AU - Whitcomb, J. M. AU - Collier, A. C. AU - Hirsch, M. S. AU - Tebas, P. AU - Sommadossi, J. P. AU - Richman, D. D. PY - 2000 DA - 2000// TI - Drug Susceptibility in HIV infection after Viral Rebound in Patients Recieving Indinavir-Containing Regimens JO - JAMA VL - 283 UR - https://doi.org/10.1001/jama.283.2.229 DO - 10.1001/jama.283.2.229 ID - Havlir2000 ER - TY - JOUR AU - Pai, N. AU - Lawrence, J. AU - Reingold, A. L. AU - Tulsky, J. PY - 2006 DA - 2006// TI - Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults JO - Cochrane Database of Systematic Reviews VL - 3 ID - Pai2006 ER - TY - JOUR AU - Chesney, M. A. AU - Morin, M. AU - Sherr, L. PY - 2000 DA - 2000// TI - Adherence to HIV combination therapy JO - Social Science & Medicine VL - 50 UR - https://doi.org/10.1016/S0277-9536(99)00468-2 DO - 10.1016/S0277-9536(99)00468-2 ID - Chesney2000 ER - TY - JOUR AU - Curlin, M. E. AU - Wilkin, T. AU - Mittler, J. PY - 2008 DA - 2008// TI - Induction-maintenance therapy for HIV-1 infection JO - Future HIV Therapy VL - 2 UR - https://doi.org/10.2217/17469600.2.2.175 DO - 10.2217/17469600.2.2.175 ID - Curlin2008 ER - TY - JOUR AU - Cohen, C. J. AU - Colson, A. E. AU - Sheble-Hall, A. G. AU - McLaughlin, K. A. AU - Morse, G. D. PY - 2007 DA - 2007// TI - Pilot Study of a Novel Short-Cycle Antiretroviral Treatment Interruption Strategy: 48-Week Results of the Five-Days-On, Two-Days-Off (FOTO) Study JO - HIV Clin Trials VL - 8 UR - https://doi.org/10.1310/hct0801-19 DO - 10.1310/hct0801-19 ID - Cohen2007 ER - TY - JOUR AU - Smith, R. J. AU - Wahl, L. M. PY - 2005 DA - 2005// TI - Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects JO - Bull Math Biol VL - 67 UR - https://doi.org/10.1016/j.bulm.2004.10.004 DO - 10.1016/j.bulm.2004.10.004 ID - Smith2005 ER - TY - JOUR AU - Smith, R. J. AU - Aggarwala, B. D. PY - 2009 DA - 2009// TI - Can the viral reservoir of latently infected CD4+ T cells be eradicated with antiretroviral drugs? JO - J Math Biol VL - 59 UR - https://doi.org/10.1007/s00285-008-0245-4 DO - 10.1007/s00285-008-0245-4 ID - Smith2009 ER - TY - BOOK AU - Bainov, D. D. AU - Simeonov, P. S. PY - 1989 DA - 1989// TI - Systems with Impulsive Effect PB - Ellis Horwood Ltd CY - Chichester ID - Bainov1989 ER - TY - BOOK AU - Bainov, D. D. AU - Simeonov, P. S. PY - 1993 DA - 1993// TI - Impulsive differential equations: periodic solutions and applications PB - Longman Scientific and Technical CY - Burnt Mill ID - Bainov1993 ER - TY - BOOK AU - Bainov, D. D. AU - Simeonov, P. S. PY - 1995 DA - 1995// TI - Impulsive Differential Equations: Asymptotic Properties of the Solutions PB - World Scientific CY - Singapore ID - Bainov1995 ER - TY - BOOK AU - Lakshmikantham, V. AU - Bainov, D. D. AU - Simeonov, P. S. PY - 1989 DA - 1989// TI - Systems with Impulsive Effect PB - World Scientific CY - Singapore ID - Lakshmikantham1989 ER - TY - JOUR AU - El-Sadr, W. M. AU - Lundgren, J. D. PY - 2006 DA - 2006// TI - CD4+ count-guided interruption of antiretroviral treatment JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa062360 DO - 10.1056/NEJMoa062360 ID - El-Sadr2006 ER - TY - JOUR PY - 2008 DA - 2008// TI - Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts < 200 cells/microl JO - AIDS VL - 22 UR - https://doi.org/10.1097/QAD.0b013e3282f2d760 DO - 10.1097/QAD.0b013e3282f2d760 ID - ref33 ER - TY - JOUR AU - Holkmann Olsen, C. AU - Mocroft, A. AU - Kirk, O. AU - Vella, S. AU - Blaxhult, A. AU - Clumeck, N. AU - Fisher, M. AU - Katlama, C. AU - Phillips, A. AU - Lundgren, J. PY - 2007 DA - 2007// TI - Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death JO - HIV Med VL - 8 UR - https://doi.org/10.1111/j.1468-1293.2007.00436.x DO - 10.1111/j.1468-1293.2007.00436.x ID - Holkmann Olsen2007 ER - TY - JOUR AU - Li, X. AU - Margolick, J. AU - Conover, C. AU - Badri, S. AU - Riddler, S. A. AU - Witt, M. D. AU - Jacobson, L. P. PY - 2005 DA - 2005// TI - Interruption and Discontinuation of Highly Active Antiretroviral Therapy in the Multicenter AIDS Cohort Study JO - JAIDS VL - 38 ID - Li2005 ER - TY - JOUR AU - Papasavvas, E. AU - Kostman, J. R. AU - Mounzer, K. AU - Grant, R. M. AU - Gross, R. AU - Gallo, C. AU - Azzoni, L. AU - Foulkes, A. AU - Thiel, B. AU - Pistilli, M. AU - Mackiewicz, A. AU - Shull, J. AU - Montaner, L. J. PY - 2004 DA - 2004// TI - Randomized, Controlled Trial of Therapy Interruption in Chronic HIV-1 Infection JO - PLoS Medicine VL - 1 UR - https://doi.org/10.1371/journal.pmed.0010064 DO - 10.1371/journal.pmed.0010064 ID - Papasavvas2004 ER - TY - STD TI - Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. 2008, 1-139. [http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf] UR - http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf ID - ref37 ER - TY - JOUR AU - Ait-Khaled, M. AU - Stone, C. AU - Amphlett, G. AU - Clotet, B. AU - Staszewski, S. AU - Katlama, C. AU - Tisdale, M. PY - 2002 DA - 2002// TI - M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine JO - AIDS VL - 16 UR - https://doi.org/10.1097/00002030-200208160-00017 DO - 10.1097/00002030-200208160-00017 ID - Ait-Khaled2002 ER - TY - JOUR AU - Smith, R. J. AU - Schwartz, E. J. PY - 2008 DA - 2008// TI - Predicting the potential impact of a cytotoxic T-lymphocyte HIV vaccine: how often should you vaccinate and how strong should the vaccine be? JO - Math Biosci VL - 212 UR - https://doi.org/10.1016/j.mbs.2008.02.001 DO - 10.1016/j.mbs.2008.02.001 ID - Smith2008 ER - TY - JOUR AU - Chun, T. W. AU - Nickle, D. C. AU - Justement, J. S. AU - Meyers, J. H. AU - Roby, G. AU - Hallahan, C. W. AU - Kottilil, S. AU - Moir, S. AU - Mican, J. M. AU - Mullins, J. I. AU - Ward, D. J. AU - Kovacs, J. A. AU - Mannon, P. J. AU - Fauci, A. S. PY - 2008 DA - 2008// TI - Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy JO - J Infect Dis VL - 197 UR - https://doi.org/10.1086/527324 DO - 10.1086/527324 ID - Chun2008 ER - TY - JOUR AU - Scott, L. AU - Perry, C. PY - 2000 DA - 2000// TI - Delavirdine - A review of its use in HIV infection JO - Drugs VL - 60 UR - https://doi.org/10.2165/00003495-200060060-00013 DO - 10.2165/00003495-200060060-00013 ID - Scott2000 ER - TY - JOUR AU - Perry, C. AU - Noble, S. PY - 1999 DA - 1999// TI - Didanosine - An update review of its use in HIV infection JO - Drugs VL - 58 UR - https://doi.org/10.2165/00003495-199958060-00009 DO - 10.2165/00003495-199958060-00009 ID - Perry1999 ER - TY - JOUR AU - Bhana, N. AU - Ormrod, D. AU - Perry, C. AU - Figgitt, D. PY - 2002 DA - 2002// TI - Zidovudine - A review of its use in management of vertically-aquired pediatric HIV infection JO - Drugs VL - 4 ID - Bhana2002 ER - TY - JOUR AU - Hervey, P. AU - Perry, C. PY - 2000 DA - 2000// TI - Abacavir - A review of its clinical potential in patients with HIV infection JO - Drugs VL - 60 UR - https://doi.org/10.2165/00003495-200060020-00015 DO - 10.2165/00003495-200060020-00015 ID - Hervey2000 ER - TY - JOUR AU - Frampton, J. AU - Perry, C. PY - 2006 DA - 2006// TI - Emtricitabine - A review of its use in management of HIV infection JO - Drugs VL - 65 UR - https://doi.org/10.2165/00003495-200565100-00008 DO - 10.2165/00003495-200565100-00008 ID - Frampton2006 ER - TY - JOUR AU - Moore, K. H. P. AU - Barrett, J. E. AU - Shaw, S. AU - Pakes, G. E. AU - Churchus, R. AU - Kapoor, A. AU - Barry, M. G. AU - D, B. PY - 1999 DA - 1999// TI - The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1 JO - AIDS VL - 13 UR - https://doi.org/10.1097/00002030-199911120-00006 DO - 10.1097/00002030-199911120-00006 ID - Moore1999 ER - TY - JOUR AU - Fletcher, C. AU - Brundage, R. AU - Remmel, R. AU - Page, L. AU - Weller, D. AU - Calles, N. AU - Simon, C. AU - Kline, M. PY - 2000 DA - 2000// TI - Pharmacologic characteristics of indinivir, didanosine, stavudine, in human immunodeficiency virus-infected children receiving combination therapy JO - Antimicrobial Agents and Chemotherapy VL - 44 UR - https://doi.org/10.1128/AAC.44.4.1029-1034.2000 DO - 10.1128/AAC.44.4.1029-1034.2000 ID - Fletcher2000 ER - TY - JOUR AU - Hawkins, T. AU - Veikley, W. AU - St Claire, R. AU - Guyer, B. AU - Clark, N. AU - Kearney, B. PY - 2001 DA - 2001// TI - Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens JO - J Acquir Defic Syndr VL - 39 UR - https://doi.org/10.1097/01.qai.0000167155.44980.e8 DO - 10.1097/01.qai.0000167155.44980.e8 ID - Hawkins2001 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/10/6/prepub UR - http://www.biomedcentral.com/1471-2334/10/6/prepub ID - ref49 ER -